Fig. 7From: Synthetic carbohydrate-based vaccines: challenges and opportunitiesStructures of (a) Synthetic glycoconjugate against Shigella dysenteriae type- 1 44. (b) Synthetic glycoconjugates against Shigella flexneri 2a 45–47Back to article page